Hostile takeovers: viral appropriation of the NF-kappaB pathway

J Clin Invest. 2001 Jan;107(2):143-51. doi: 10.1172/JCI11918.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Antigens, Viral / physiology
  • CD4-Positive T-Lymphocytes / immunology
  • CD4-Positive T-Lymphocytes / virology
  • Cell Line
  • Cell Transformation, Viral / immunology*
  • Enzyme Activation
  • Gene Products, tax / physiology
  • HIV Infections / metabolism
  • HIV-1*
  • Herpesvirus 4, Human
  • Human T-lymphotropic virus 1
  • Humans
  • I-kappa B Kinase
  • Mice
  • NF-kappa B / antagonists & inhibitors
  • NF-kappa B / genetics
  • NF-kappa B / physiology*
  • Phenotype
  • Phosphorylation
  • Protein Serine-Threonine Kinases / antagonists & inhibitors
  • Protein Serine-Threonine Kinases / deficiency
  • Protein Serine-Threonine Kinases / genetics
  • Protein Serine-Threonine Kinases / metabolism
  • Signal Transduction
  • Viral Matrix Proteins / physiology
  • Virus Replication

Substances

  • Antigens, Viral
  • EBV-associated membrane antigen, Epstein-Barr virus
  • Gene Products, tax
  • NF-kappa B
  • Viral Matrix Proteins
  • Protein Serine-Threonine Kinases
  • CHUK protein, human
  • Chuk protein, mouse
  • I-kappa B Kinase
  • IKBKB protein, human
  • IKBKE protein, human
  • Ikbkb protein, mouse
  • Ikbke protein, mouse